nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroxoline—METAP2—hematopoietic system—stomach cancer	0.137	0.185	CbGeAlD
Nitroxoline—METAP2—smooth muscle tissue—stomach cancer	0.121	0.163	CbGeAlD
Nitroxoline—METAP2—lymphoid tissue—stomach cancer	0.0965	0.13	CbGeAlD
Nitroxoline—METAP2—digestive system—stomach cancer	0.0953	0.129	CbGeAlD
Nitroxoline—METAP2—bone marrow—stomach cancer	0.0879	0.118	CbGeAlD
Nitroxoline—METAP2—endocrine gland—stomach cancer	0.0788	0.106	CbGeAlD
Nitroxoline—METAP2—liver—stomach cancer	0.071	0.0958	CbGeAlD
Nitroxoline—METAP2—lymph node—stomach cancer	0.0545	0.0734	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—RBP1—stomach cancer	0.0404	0.157	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—RBP4—stomach cancer	0.0207	0.0802	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—AKR1C3—stomach cancer	0.0173	0.0671	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—APOA1—stomach cancer	0.00933	0.0361	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PGLS—stomach cancer	0.00538	0.0209	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RBP1—stomach cancer	0.00514	0.0199	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FBP1—stomach cancer	0.00458	0.0177	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PGAM1—stomach cancer	0.00408	0.0158	CbGpPWpGaD
Nitroxoline—METAP2—Disease—WIF1—stomach cancer	0.00389	0.0151	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KISS1R—stomach cancer	0.00377	0.0146	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GLI3—stomach cancer	0.00377	0.0146	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPL13—stomach cancer	0.00366	0.0142	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPL18—stomach cancer	0.00366	0.0142	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RBP1—stomach cancer	0.0036	0.0139	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RNF43—stomach cancer	0.00347	0.0134	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS21—stomach cancer	0.00341	0.0132	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS15—stomach cancer	0.00341	0.0132	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—WWOX—stomach cancer	0.00293	0.0114	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ALDOB—stomach cancer	0.00283	0.011	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPL15—stomach cancer	0.00277	0.0107	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—WIF1—stomach cancer	0.00273	0.0106	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HRH4—stomach cancer	0.00273	0.0106	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NPM1—stomach cancer	0.00272	0.0105	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RBP4—stomach cancer	0.00263	0.0102	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS26—stomach cancer	0.00259	0.01	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PPIA—stomach cancer	0.00257	0.00994	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKAB1—stomach cancer	0.00252	0.00974	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KISS1—stomach cancer	0.00243	0.00941	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RNF43—stomach cancer	0.00243	0.00941	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKR1C3—stomach cancer	0.0022	0.00852	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS19—stomach cancer	0.0022	0.00852	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FST—stomach cancer	0.00217	0.00839	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ENO1—stomach cancer	0.00214	0.0083	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RGS2—stomach cancer	0.00209	0.00809	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GAST—stomach cancer	0.00209	0.00809	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGG—stomach cancer	0.00198	0.00767	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS6—stomach cancer	0.00195	0.00753	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKAA1—stomach cancer	0.00191	0.00739	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CD44—stomach cancer	0.0019	0.00736	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RBP4—stomach cancer	0.00184	0.00713	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HBEGF—stomach cancer	0.00179	0.00692	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PPP2R1A—stomach cancer	0.00162	0.00626	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HSPB1—stomach cancer	0.00158	0.00613	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AGTR2—stomach cancer	0.00158	0.00613	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—F2R—stomach cancer	0.00157	0.00606	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BMP2—stomach cancer	0.00157	0.00606	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKR1C3—stomach cancer	0.00154	0.00597	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HTR1A—stomach cancer	0.00152	0.0059	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SMAD4—stomach cancer	0.0015	0.00581	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ANXA1—stomach cancer	0.00147	0.0057	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADRB1—stomach cancer	0.00143	0.00552	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FYN—stomach cancer	0.00143	0.00552	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ERCC2—stomach cancer	0.00137	0.00531	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RPS6—stomach cancer	0.00136	0.00528	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGFR2—stomach cancer	0.00134	0.00518	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTHFR—stomach cancer	0.00129	0.00499	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HBEGF—stomach cancer	0.00125	0.00485	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IRS2—stomach cancer	0.00123	0.00475	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CAV1—stomach cancer	0.00119	0.0046	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APOA1—stomach cancer	0.00119	0.00459	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADRB2—stomach cancer	0.00116	0.00447	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PPP2R1A—stomach cancer	0.00113	0.00438	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IL6ST—stomach cancer	0.00113	0.00436	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APC—stomach cancer	0.00108	0.00419	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SMAD4—stomach cancer	0.00105	0.00407	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IL6R—stomach cancer	0.001	0.00389	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FYN—stomach cancer	0.000998	0.00387	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SERPINE1—stomach cancer	0.000941	0.00364	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGFR2—stomach cancer	0.000937	0.00363	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RHOA—stomach cancer	0.000908	0.00352	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOS3—stomach cancer	0.000898	0.00348	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IRS2—stomach cancer	0.000858	0.00332	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ERBB2—stomach cancer	0.00084	0.00325	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CAV1—stomach cancer	0.000832	0.00322	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APOA1—stomach cancer	0.00083	0.00321	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTGS2—stomach cancer	0.000822	0.00318	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKCB—stomach cancer	0.000792	0.00307	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL6ST—stomach cancer	0.000789	0.00305	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CDKN1B—stomach cancer	0.000778	0.00301	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APC—stomach cancer	0.000758	0.00293	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CDKN1A—stomach cancer	0.000718	0.00278	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL6R—stomach cancer	0.000704	0.00273	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SERPINE1—stomach cancer	0.000659	0.00255	CbGpPWpGaD
Nitroxoline—METAP2—Disease—STAT3—stomach cancer	0.000641	0.00248	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RHOA—stomach cancer	0.000636	0.00246	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOS3—stomach cancer	0.000629	0.00244	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MAPK3—stomach cancer	0.000612	0.00237	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MYC—stomach cancer	0.000595	0.00231	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ERBB2—stomach cancer	0.000588	0.00228	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MAPK1—stomach cancer	0.000582	0.00226	CbGpPWpGaD
Nitroxoline—METAP2—Disease—EGFR—stomach cancer	0.000582	0.00226	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCL8—stomach cancer	0.000558	0.00216	CbGpPWpGaD
Nitroxoline—METAP2—Disease—KRAS—stomach cancer	0.00055	0.00213	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDKN1B—stomach cancer	0.000545	0.00211	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCND1—stomach cancer	0.00052	0.00201	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JUN—stomach cancer	0.000519	0.00201	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CA—stomach cancer	0.000505	0.00196	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MMP9—stomach cancer	0.000505	0.00195	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDKN1A—stomach cancer	0.000503	0.00195	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK8—stomach cancer	0.000491	0.0019	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HRAS—stomach cancer	0.000468	0.00181	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—VEGFA—stomach cancer	0.000453	0.00176	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STAT3—stomach cancer	0.000449	0.00174	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IL6—stomach cancer	0.000448	0.00173	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK3—stomach cancer	0.000429	0.00166	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MYC—stomach cancer	0.000417	0.00161	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK1—stomach cancer	0.000408	0.00158	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EGFR—stomach cancer	0.000408	0.00158	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KRAS—stomach cancer	0.000385	0.00149	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CA—stomach cancer	0.000354	0.00137	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TP53—stomach cancer	0.000342	0.00133	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HRAS—stomach cancer	0.000327	0.00127	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL6—stomach cancer	0.000313	0.00121	CbGpPWpGaD
